1. Kiely M. Viagra saturates media. Marketing Globe. Marketing 1998; Dec: 58.
2. Jones A. When the thrill has gone. Business Rev Weekly 1999; June 25: 90-95.
3. Pfizer, Inc. Annual Report, 1999.
4. Food and Drug Administration. Postmarketing safety of sildenafil citrate (Viagra): summary of reports of death in Viagra users received from marketing (late March through mid-November 1998 online). Available from: URL: http://www.fda.gov/-cder/consumerinfo/viagra/safety3.htm [Accessed 2000 Jun 6].
5. Siegel-Itzkovich J. Israel bans import of sildenafil citrate after six deaths in the US. BMJ 1998; 316: 1625.
6. Chew KK, Stuckey BGA, Thompson PL. Erectile dysfunction, sildenafil and cardiovascular risk. Med J Austral 2000; 172; 279-283.
7. Feenstra J, van Drie-Pierik RJHM, Lacle CF, Stricker BHC. Acute myocardial infarction associated with sildenafil. Lancet 1998; 352: 957-958.
8. Viagra is here! Australian Adverse Drug Reactions Bulletin 1998; 17(4).
9. Sildenafil (Viagra): cardiac risks. Canadian Adverse Drug Reaction Newsletter 2000; 10 (3): 4-6.
10. Azarbal B, et al. Adverse cardiovascular events associated with the use of Viagra. J Am Coll Cardiol 2000; 35 Suppl. A: A553-A554.
11. Mitka M. Some men who take Vigara die-why?.JAMA 2000; 283: 590-593.
12. Herrmann HC, Chang G, Klugherz BD, Mahoney PD. Hemodynamic effects of sildenafil in men with severe coronary artery disease. N Engl J Med 2000; 342: 1622-1626).
13. Jackson G, Benjamin N, Jackson N, Allen MJ. Effect of sildenafil citrate on human hemodynamics. Am J Cardiol 1999; 83: 13C-20C.
14. Cheitlin MD, Hutter AM Jr., Brindis RG, Ganz P, Kaul S, Russell RO Jr, Zusman RM. Use of sildenafil (viagra) in pateients with cardiovascular disease. Circulation 1999; 99: 168-177 [Erratum, Circulation 1999; 100: 2389].
15. Willich SN, Klatt S, Arntz HR. Circadian variation and triggers of acute coronary syndromes. Eur Heart J 1998; 19 Suppl C: C12-23.
16. Nalbangtil I, Yigitbasi O, Kiliccioglu B. Sudden death in sexual activity. Am Heart J 1976; 91: 405-406.
17. Ueno M. The so-called coital death. Jpn J Legal Med 1963; 17: 330-340.
18. Renshaw DC, Karstaedt A. Is there (sex) life after coronary bypass? Comp Ther 1988; 14: 61-66.
19. Lecomte D, Fornes P, Nicolas G. Stressful events as a trigger of sudden death: a study of 43 medico-legal autopsy cases. Forensic Sci Int 1996; 79: 1-10.
20. Muller JE, Mittleman MA, Maclure M, et al. Triggering myocardial infarction by sexual activity. JAMA 1996; 275: 1405-1409.
21. Johnston BL, Fletcher GF. Dynamic electrocardiographic recording during sexual activity in recent post-myocardial infarction and revascularization patients. Am Heart J 1979; 98: 736-741.
22. Drory Y, Shapira I, Fisman EZ, Pines A. Myocardial ischaemia during sexual activity in patients with coronary artery disease. Am J Cardiol 1995; 75: 835-837.
23. Paolillo V, Marra S, Spadaccini F, Angelino PF. Dynamic electrocardiographic recording during sexual activity in recent post-myocardial infarction and revascularization patients [letter]. Am Heart J 1980; 100: 763.
24. Cardiac rehabilitation: sex after a heart attack. In: Zaret BL, Moser M, Cohen LS, editors. Yale University School of Medicine Heart Book. New York: Hearst Books, 1992; 351.
25. Tardif GS. Sexual activity after a myocardial infarction. Arch Phys Med Rehabil 1989; 70: 763-766.
26. Cheitlin MD, Hutter AM Jr, Brindis RG, Ganz P, Kaul S, Russell RO Jr, Zusman RM. ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. J Am Coll Cardiol 1999; 33:273-82
27. Cohen JS. Should patients be given an initial low test dose of sildenafil? Drug Saf 2000; 23: 1-9.
28. Hayashi K, et al. Atrial fibrillation and continuous hypotension induced by sildenafil in an intermittent WPW syndrome patient. Jpn Heart J 1999; 40: 827-830.
29. Donahue SP, Taylor RJ. Pupil-sparing third nerve palsy associated with sildenafil citrate (Viagra). Am J Ophthalmol 1998; 126: 476-477.
30. Arora RR, et al. Acute myocardial infarction after the use of sildenafil. N Engl J Med 1999; 341: 700.
31. Summary statement of the American College of Cardiology and the American Heart Association on the use of sildenafil (Viagra) in patients at clinical risk from cardiovascular effects. 10 August 1998. <http://www.americanheart.org/Whats_News/AHA_Science_Advisories/viagra.html>. Accessed 18 February 2000.